Literature DB >> 15221428

Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.

María Gracia Caletti1, Horacio Lejarraga, Diana Kelmansky, Mabel Missoni.   

Abstract

Renal disease is the most important long-term complication of hemolytic-uremic syndrome (HUS). A comparative study of renal function was carried out in two groups of patients. Group 1 included 19 children followed for a median of 11 years, 1960-1980, with a low-sodium diet, antihypertensive drugs, and a restricted protein intake in the end stage of renal disease. Group 2 included 26 children treated for a median of 9 years, 1988-2002, on a low-sodium diet, early restriction of protein intake according to recommendations, and angiotensin converting enzyme inhibitors (ACEi). Long-term renal function was assessed by the inverse of the plasma creatinine concentration (1/[Cr]) over time. Linear regression lines were fitted to individual values of 1/[Cr] for each child. Regression coefficients of children in group 1 were all negative, ranging from -0.031 to -0.00043; 7 were significantly different from zero, indicating a linear fall in renal function over time. In contrast, children from group 2 had 11 negative slopes (only 1 significant) and 15 positive slopes, ranging from 0.17893 to -0.3899. Fisher's exact test showed that group 1 had significantly more children with negative slopes than group 2. This comparatively better long-term outcome of renal function in children under contemporary treatment was probably associated with early restriction of protein and use of ACEi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221428     DOI: 10.1007/s00467-004-1516-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  40 in total

1.  Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR.

Authors:  J A Benstein; H D Feiner; M Parker; L D Dworkin
Journal:  Am J Physiol       Date:  1990-06

2.  A simple method of estimating progression of chronic renal failure.

Authors:  W E Mitch; M Walser; G A Buffington; J Lemann
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

3.  Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet.

Authors:  L Oldrizzi; C Rugiu; E Valvo; A Lupo; C Loschiavo; L Gammaro; N Tessitore; A Fabris; G Panzetta; G Maschio
Journal:  Kidney Int       Date:  1985-03       Impact factor: 10.612

4.  Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.

Authors:  C Loirat; E Sonsino; A Varga Moreno; G Pillion; J C Mercier; F Beaufils; H Mathieu
Journal:  Acta Paediatr Scand       Date:  1984-07

Review 5.  Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure.

Authors:  S Klahr
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

Review 6.  Infantile nephrotic syndrome.

Authors:  C R George; R O Hickman; G E Stricker
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

7.  Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features.

Authors:  A Kelles; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

8.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

Authors:  M Ravid; R Lang; R Rachmani; M Lishner
Journal:  Arch Intern Med       Date:  1996-02-12

9.  Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.

Authors:  M Praga; E Hernández; C Montoyo; A Andrés; L M Ruilope; J L Rodicio
Journal:  Am J Kidney Dis       Date:  1992-09       Impact factor: 8.860

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  7 in total

1.  Methods for characterizing differences in longitudinal glomerular filtration rate changes between children with glomerular chronic kidney disease and those with nonglomerular chronic kidney disease.

Authors:  Christopher B Pierce; Christopher Cox; Jeffrey M Saland; Susan L Furth; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2011-08-09       Impact factor: 4.897

2.  Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.

Authors:  Maria Gracia Caletti; Mabel Missoni; Clarisa Vezzani; María Grignoli; Juan Jose Piantanida; Horacio A Repetto; Ramon Exeni; Stella Maris Rasse
Journal:  Pediatr Nephrol       Date:  2011-04-30       Impact factor: 3.714

3.  Incidence of Initial Renal Replacement Therapy Over the Course of Kidney Disease in Children.

Authors:  Derek K Ng; Matthew B Matheson; Bradley A Warady; Susan R Mendley; Susan L Furth; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

4.  Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Adriana Haydeé Roy
Journal:  Pediatr Nephrol       Date:  2010-02-16       Impact factor: 3.714

5.  Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents.

Authors:  George J Schwartz; Jennifer L Roem; Stephen R Hooper; Susan L Furth; Donald J Weaver; Bradley A Warady; Michael F Schneider
Journal:  Pediatr Nephrol       Date:  2022-06-01       Impact factor: 3.714

6.  Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Mabel Missoni; Clarisa Vezzani
Journal:  Pediatr Nephrol       Date:  2012-12-20       Impact factor: 3.714

Review 7.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.